Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05036330 · ClinicalTrials.gov registry record
ProvoxLife Adoption Trends for Heat-Moisture Exchanger
A clinical trial of Malignant Head and Neck Neoplasm, sponsored by M.D. Anderson Cancer Center.
- Active
- Registry status
- 130
- Enrollment target
- 1
- Study location
NCT05036330: Active study of Malignant Head and Neck Neoplasm, sponsored by M.D. Anderson Cancer Center.
NCT05036330 is a study of Malignant Head and Neck Neoplasm that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 130 participants, below the 310-participant average among 5 other Malignant Head and Neck Neoplasm trials with a reported enrollment target (58% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05036330, a study of Malignant Head and Neck Neoplasm, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- 130 participants
- Enrollment target
- 1
- Study location
Study Summary
This study examines factors that affect how often patients who have a total laryngectomy use a ProvoxLife heat-moisture exchanger (HME) system to help improve their lung function. ProvoxLife HMEs are single use heat- and moisture exchangers for patients breathing through a tracheostoma. Information from this study may help doctors learn more about factors associated with patterns of use and how often patients use the ProvoxLife HME system.
Conditions Studied
Interventions
- OTHER Quality-of-Life Assessment
- OTHER Questionnaire Administration
- OTHER Clinical Evaluation
- PROCEDURE Physical Examination
Study Locations (1)
Texas
- M D Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 2021-05-21 |
| Est. Completion | 2027-02-02 |
What the registry record for NCT05036330 still lists
NCT05036330 is an observational study that tracks outcomes without assigning an intervention. The registered 130 participants enrollment target is mid-sized for trials with a published cap, below the 310-participant average among 5 other Malignant Head and Neck Neoplasm trials with a reported enrollment target (58% lower).
The record links to 1 condition, with Malignant Head and Neck Neoplasm appearing as the primary indexed condition, and to 4 interventions - of which Quality-of-Life Assessment is the first listed.
NCT05036330 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT05036330 about?
NCT05036330 is a clinical study titled "ProvoxLife Adoption Trends for Heat-Moisture Exchanger". This study examines factors that affect how often patients who have a total laryngectomy use a ProvoxLife heat-moisture exchanger (HME) system to help improve their lung function. ProvoxLife HMEs are single use heat- and moisture exchangers for patients breathing through a tracheostoma. Information ...
What is the current status of trial NCT05036330?
This trial is currently active not recruiting. The enrollment target is 130 participants. The study started on 2021-05-21. Estimated completion is 2027-02-02.
What conditions does trial NCT05036330 study?
This clinical trial studies the following conditions: Malignant Head and Neck Neoplasm.
What interventions are being tested in trial NCT05036330?
The interventions under investigation include: Quality-of-Life Assessment (OTHER), Questionnaire Administration (OTHER), Clinical Evaluation (OTHER), Physical Examination (PROCEDURE).
Who is sponsoring clinical trial NCT05036330?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05036330 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Malignant Head and Neck Neoplasm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"
RECRUITING · NA
-
Yoga Program for Improving the Quality of Life in Couples Coping With Cancer
ACTIVE NOT RECRUITING · NA
-
Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction
ACTIVE NOT RECRUITING · Phase 1
-
Pro-Active Genetic Testing in Patients With Solid Tumors, Inherit Study
COMPLETED · Phase 1
-
Prepare to Care, A Supported Self-Management Intervention for Head and Neck Cancer CaregiversHead and Neck Cancer
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01492036 · 130 participants
Long-Term Follow-Up of Recipient of Gene Transfer Research
- NCT01631617 · 130 participants · Phase 2
Effects of Treatments on Atopic Dermatitis
- NCT02368041 · 130 participants
Utility of Thenar Near Infrared Spectroscopy (NIRS) in Pediatric Patients With Heart Failure
- NCT02604277 · 130 participants · NA
Suicidal Behavior in Patients Diagnosed With Bipolar Disorder
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI